Selected article for: "study drug and test drug"
Author: He, Jiayang; Li, Zhengtu; Huang, Wanyi; Guan, Wenda; Ma, Hongxia; Yang, Zi feng; Wang, Xinhua
Title: Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial
  • Document date: 2019_4_2
    • ID: vn9e5nm3_56
    Snippet: The adverse event is definitely caused by other reasons, and not the test drug. Study flowchart. Participants that meet the inclusion criteria will be recruited and assigned randomly into three different groups. All participants will accept a 5-day treatment and 21-day follow-up period of observation. Data will be collected to evaluate the treatment efficacy and safety of Chou-Ling-Dan (CLD)......
    Document: The adverse event is definitely caused by other reasons, and not the test drug. Study flowchart. Participants that meet the inclusion criteria will be recruited and assigned randomly into three different groups. All participants will accept a 5-day treatment and 21-day follow-up period of observation. Data will be collected to evaluate the treatment efficacy and safety of Chou-Ling-Dan (CLD).

    Search related documents:
    Co phrase search for related documents
    • adverse event and follow period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adverse event and inclusion criterion: 1
    • adverse event and safety treatment efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adverse event and test drug: 1, 2, 3
    • adverse event and treatment efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
    • different group and follow period: 1, 2, 3, 4, 5, 6, 7, 8
    • different group and test drug: 1
    • different group and treatment efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • follow period and inclusion criterion: 1, 2
    • follow period and observation follow period: 1, 2, 3, 4, 5
    • follow period and observation follow period treatment: 1
    • follow period and observation follow period treatment accept: 1
    • follow period and safety treatment efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • follow period and study flowchart: 1
    • follow period and test drug: 1
    • follow period and treatment efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • inclusion criterion and treatment efficacy: 1
    • observation follow period and safety treatment efficacy: 1
    • observation follow period and study flowchart: 1